The company had reported a net profit of Rs 343 crore for the corresponding quarter last year.
Cipla may post 21 per cent year-on-year rise in revenue at Rs 3,770 crore in Q3 of FY17 over Rs 3,106 crore in Q3 of FY16.
Ebitda figures may surge by 50 per cent year-on-year to Rs 680 crore from Rs 453 crore in the same quarter last year.
There are expectations that the export formulations business may witness robust growth on Invagen acquisition. However, India business growth seen muted at 8-10 per cent on account of demonetisation of high-value currency notes on November 8.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price